A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)
NCT ID: NCT07076121
Last Updated: 2026-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE2/PHASE3
470 participants
INTERVENTIONAL
2025-10-23
2029-05-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer
NCT07283705
Gemcitabine and Nab-paclitaxel Combined With Momelotinib in Participants With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma
NCT02101021
A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer
NCT02399137
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
NCT05254171
A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma
NCT02993731
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm A
BMS-986504
Specified dose on specified days
Gemcitabine
Specified dose on specified days
Nab-paclitaxel
Specified dose on specified days
Arm B
BMS-986504
Specified dose on specified days
Gemcitabine
Specified dose on specified days
Nab-paclitaxel
Specified dose on specified days
Arm C
Gemcitabine
Specified dose on specified days
Nab-paclitaxel
Specified dose on specified days
Placebo
Specified dose on specified days
Arm D
Gemcitabine
Specified dose on specified days
Nab-paclitaxel
Specified dose on specified days
Placebo
Specified dose on specified days
Arm E
BMS-986504
Specified dose on specified days
Gemcitabine
Specified dose on specified days
Nab-paclitaxel
Specified dose on specified days
Arm F
Gemcitabine
Specified dose on specified days
Nab-paclitaxel
Specified dose on specified days
Placebo
Specified dose on specified days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BMS-986504
Specified dose on specified days
Gemcitabine
Specified dose on specified days
Nab-paclitaxel
Specified dose on specified days
Placebo
Specified dose on specified days
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Evidence of homozygous methylthioadenosine phosphorylase (MTAP) deletion or MTAP loss detected in tumor tissue.
* Metastatic disease with at least 1 measurable lesion as per Response Evaluation Criteria in Solid Tumors version v1.1 (RECIST v1.1).
* Participants must not have received any systemic anticancer treatments in the metastatic setting.
* If clinically indicated and as per investigator discretion, participants may receive up to 1 cycle of Nab-paclitaxel/Gemcitabine (nab-p/gem) in the metastatic setting and must have not progressed or required discontinuation due to intolerable toxicity.
* Initial cycle of nab-p/gem administered in the metastatic setting must have been completed prior to randomization.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bristol-Myers Squibb
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Bristol-Myers Squibb
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Local Institution - 0142
Phoenix, Arizona, United States
Local Institution - 0365
Tucson, Arizona, United States
Highlands Oncology Group
Springdale, Arkansas, United States
Local Institution - 0373
La Jolla, California, United States
Local Institution - 0157
San Francisco, California, United States
Local Institution - 0139
Jacksonville, Florida, United States
Local Institution - 0132
Tampa, Florida, United States
Local Institution - 0367
Atlanta, Georgia, United States
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital
Marietta, Georgia, United States
Local Institution - 0126
Boise, Idaho, United States
Local Institution - 0168
Chicago, Illinois, United States
Local Institution - 0125
Westwood, Kansas, United States
Local Institution - 0370
Louisville, Kentucky, United States
Local Institution - 0371
Baltimore, Maryland, United States
Local Institution - 0145
Baltimore, Maryland, United States
Local Institution - 0245
Boston, Massachusetts, United States
Local Institution - 0120
Boston, Massachusetts, United States
Local Institution - 0191
Detroit, Michigan, United States
The Cancer & Hematology Centers
Grand Rapids, Michigan, United States
Local Institution - 0182
Rochester, Minnesota, United States
University Of Nebraska Medical Center
Omaha, Nebraska, United States
Local Institution - 0144
Buffalo, New York, United States
Local Institution - 0377
Mineola, New York, United States
Local Institution - 0146
New Hyde Park, New York, United States
Local Institution - 0143
New York, New York, United States
Local Institution - 0140
New York, New York, United States
Local Institution - 0279
New York, New York, United States
Local Institution - 0161
Rochester, New York, United States
Local Institution - 0129
Chapel Hill, North Carolina, United States
Local Institution - 0376
Columbus, Ohio, United States
Kaiser Permanente Center for Health Research
Portland, Oregon, United States
Local Institution - 0162
Portland, Oregon, United States
St. Luke's University Health Network
Bethlehem, Pennsylvania, United States
Local Institution - 0301
Lancaster, Pennsylvania, United States
Local Institution - 0158
Philadelphia, Pennsylvania, United States
Local Institution - 0368
Pittsburgh, Pennsylvania, United States
Local Institution - 0289
Pittsburgh, Pennsylvania, United States
Local Institution - 0167
Nashville, Tennessee, United States
SCRI Oncology Partners
Nashville, Tennessee, United States
Texas Oncology - DFW
Dallas, Texas, United States
University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Local Institution - 0170
Temple, Texas, United States
Local Institution - 0344
Salt Lake City, Utah, United States
Local Institution - 0159
Fairfax, Virginia, United States
Local Institution - 0348
Norfolk, Virginia, United States
Local Institution - 0169
Seattle, Washington, United States
Local Institution - 0337
Seattle, Washington, United States
Local Institution - 0195
Milwaukee, Wisconsin, United States
Hospital Británico de Buenos Aires
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Instituto Alexander Fleming
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Local Institution - 0044
ABB, Buenos Aires F.D., Argentina
Clínica Mayo de Urgencias Médicas Cruz Blanca S.R.L
San Miguel de Tucumán, Tucumán Province, Argentina
Centro de Educación Médica e Investigaciones clínicas "Dr. Norberto Quirno" (CEMIC)
Buenos Aires, , Argentina
Local Institution - 0045
Córdoba, , Argentina
GenesisCare North Shore
St Leonards, New South Wales, Australia
Royal Brisbane and Women's Hospital
Brisbane, Queensland, Australia
Local Institution - 0226
Brisbane, Queensland, Australia
Local Institution - 0229
Woodville, South Australia, Australia
Cabrini Hospital - Malvern
Malvern, Victoria, Australia
Local Institution - 0231
Melbourne, Victoria, Australia
St. John of God Murdoch Hospital
Murdoch, Western Australia, Australia
Ordensklinikum Linz
Linz, Upper Austria, Austria
Uniklinikum Salzburg
Salzburg, , Austria
Local Institution - 0211
Vienna, , Austria
Local Institution - 0031
Bonheiden, Antwerpen, Belgium
Local Institution - 0035
Edegem, Antwerpen, Belgium
Local Institution - 0065
Brussels, Bruxelles-Capitale, Région de, Belgium
Local Institution - 0063
Brussels, Bruxelles-Capitale, Région de, Belgium
Local Institution - 0033
Ghent, Oost-Vlaanderen, Belgium
Local Institution - 0032
Leuven, Vlaams-Brabant, Belgium
Local Institution - 0034
Liège, , Belgium
Local Institution - 0102
Vitória, Espírito Santo, Brazil
Local Institution - 0291
Salvador, Estado de Bahia, Brazil
Local Institution - 0101
Belo Horizonte, Minas Gerais, Brazil
Local Institution - 0074
Natal, Rio Grande do Norte, Brazil
Local Institution - 0104
Santa Cruz do Sul, Rio Grande do Sul, Brazil
Local Institution - 0071
Barretos, São Paulo, Brazil
Local Institution - 0100
Rio de Janeiro, , Brazil
Local Institution - 0075
São Paulo, , Brazil
Local Institution - 0332
São Paulo, , Brazil
Local Institution - 0199
Calgary, Alberta, Canada
Local Institution - 0200
Vancouver, British Columbia, Canada
Local Institution - 0202
Halifax, Nova Scotia, Canada
Sunnybrook Research Institute
Toronto, Ontario, Canada
Local Institution - 0203
Toronto, Ontario, Canada
Jewish General Hospital
Montreal, Quebec, Canada
Local Institution - 0156
Viña del Mar, Región de Valparaíso, Chile
Local Institution - 0048
Santiago, Santiago Metropolitan, Chile
Local Institution - 0046
Santiago, Santiago Metropolitan, Chile
Local Institution - 0047
Santiago, Santiago Metropolitan, Chile
Local Institution - 0312
Hefei, Anhui, China
Local Institution - 0331
Hefei, Anhui, China
Local Institution - 0346
Beijing, Beijing Municipality, China
Local Institution - 0310
Beijing, Beijing Municipality, China
Local Institution - 0307
Chongqing, Chongqing Municipality, China
Local Institution - 0296
Fuzhou, Fujian, China
Local Institution - 0297
Fuzhou, Fujian, China
Local Institution - 0352
Guangzhou, Guangdong, China
Local Institution - 0313
Guangzhou, Guangdong, China
Local Institution - 0302
Harbin, Heilongjiang, China
Local Institution - 0295
Luoyang, Henan, China
Local Institution - 0353
Zhengzhou, Henan, China
Local Institution - 0357
Wuhan, Hubei, China
Local Institution - 0298
Wuhan, Hubei, China
Local Institution - 0293
Changsha, Hunan, China
Local Institution - 0354
Changzhou, Jiangsu, China
Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School
Nanjing, Jiangsu, China
Local Institution - 0311
Nanjing, Jiangsu, China
Local Institution - 0304
Shenyang, Liaoning, China
Local Institution - 0345
Xi'an, Shaanxi, China
Local Institution - 0299
Jinan, Shandong, China
Local Institution - 0334
Jining, Shandong, China
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
Local Institution - 0355
Shanghai, Shanghai Municipality, China
Local Institution - 0300
Shanghai, Shanghai Municipality, China
Local Institution - 0239
Shanghai Shi, Shanghai Municipality, China
Local Institution - 0351
Taiyuan, Shanxi, China
Sichuan Cancer hospital
Chengdu, Sichuan, China
Local Institution - 0305
Chengdu, Sichuan, China
Tianjin Tumor Hospital
Tianjin, Tianjin Municipality, China
Local Institution - 0356
Hangzhou, Zhejiang, China
Sir Run Run Shaw Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Local Institution - 0267
Medellín, Antioquia, Colombia
Local Institution - 0338
Rionegro, Antioquia, Colombia
Local Institution - 0362
Rionegro, Antioquia, Colombia
Local Institution - 0269
Montería, Departamento de Córdoba, Colombia
Local Institution - 0268
Pereira, Risaralda Department, Colombia
Local Institution - 0266
Bogotá, , Colombia
Local Institution - 0057
Brno, Brno-město, Czechia
Local Institution - 0060
Hradec Králové, Hradec Králové, Czechia
Local Institution - 0070
Olomouc, Olomoucký kraj, Czechia
Local Institution - 0058
Prague, Praha 4, Czechia
Local Institution - 0119
Prague, Praha 5, Czechia
Local Institution - 0130
Prague, , Czechia
Local Institution - 0019
Copenhagen, Capital Region, Denmark
Local Institution - 0116
Aarhus, Central Jutland, Denmark
Local Institution - 0021
Aalborg, North Denmark, Denmark
Local Institution - 0020
Odense, Region Syddanmark, Denmark
Vejle Sygehus
Vejle, Region Syddanmark, Denmark
Local Institution - 0067
Lyon, Auvergne-Rhône-Alpes, France
Centre Hospitalier Universitaire Estaing
Clermont-Ferrand, Auvergne, France
Centre Georges François Leclerc
Dijon, Côte-d'Or, France
Local Institution - 0062
Besançon, Doubs, France
CHU Rangueil
Toulouse, Haute-Garonne, France
Local Institution - 0068
Saint-Cloud, Hauts-de-Seine, France
Local Institution - 0029
Montpellier, Hérault, France
Local Institution - 0025
Vandœuvre-lès-Nancy, Meurthe-et-Moselle, France
Local Institution - 0238
Marseille, Provence-Alpes-Côte d'Azur Region, France
Centre Hospitalier de la Côte Basque
Bayonne, Pyrénées-Atlantiques, France
Gustave Roussy
Villejuif, Val-de-Marne, France
Local Institution - 0066
Poitiers, Vienne, France
Local Institution - 0028
Paris, , France
Local Institution - 0309
Villejuif, , France
Local Institution - 0242
München, Bavaria, Germany
Local Institution - 0209
Frankfurt am Main, Hesse, Germany
Universitätsmedizin Göttingen - Georg-August-Universität
Göttingen, Lower Saxony, Germany
Local Institution - 0205
Bochum, North Rhine-Westphalia, Germany
Klinikum Chemnitz - Flemmingstraße
Chemnitz, Saxony, Germany
Local Institution - 0224
Dresden, Saxony, Germany
DRK Kliniken Berlin - Köpenick
Berlin, , Germany
Local Institution - 0206
Cologne, , Germany
Facharztzentrum Eppendorf
Hamburg, , Germany
Local Institution - 0208
Ulm, , Germany
Local Institution - 0085
Athens, Attikí (Region), Greece
Local Institution - 0086
Athens, Attikí (Region), Greece
Local Institution - 0084
Athens, Attikí, Greece
Local Institution - 0259
Heraklion, Irakleío, Greece
Local Institution - 0091
Thessaloniki, Kentrikí Makedonía, Greece
Local Institution - 0082
Thessaloniki, Thessaloníki, Greece
Local Institution - 0083
Larissa, Thessalía, Greece
Local Institution - 0271
Hong Kong, , Hong Kong
Local Institution - 0270
Shatin, , Hong Kong
Local Institution - 0188
Kochi, Kerala, India
Local Institution - 0152
New Delhi, National Capital Territory of Delhi, India
Local Institution - 0179
Bhubaneswar, Odisha, India
Local Institution - 0190
Hyderabad, Telangana, India
Local Institution - 0147
Hyderabad, Telangana, India
Local Institution - 0154
Varanasi, Uttar Pradesh, India
Local Institution - 0153
Kolkata, West Bengal, India
Local Institution - 0225
Dublin, , Ireland
Local Institution - 0078
Ramat Gan, Central District, Israel
Local Institution - 0080
Ẕerifin, Central District, Israel
Local Institution - 0097
Jerusalem, Jerusalem, Israel
Local Institution - 0077
Afula, Northern District, Israel
Local Institution - 0076
Tel Aviv, Tell Abīb, Israel
Local Institution - 0081
Petah Tikva, , Israel
IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori"
Meldola, Emilia-Romagna, Italy
Local Institution - 0092
Rome, Lazio, Italy
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Lombardy, Italy
Istituto Clinico Humanitas
Rozzano, Milano, Italy
Local Institution - 0096
Pisa, Tuscany, Italy
Local Institution - 0093
Padua, Veneto, Italy
Local Institution - 0247
Milan, , Italy
Azienda Ospedaliera Universitaria Federico II
Napoli, , Italy
Local Institution - 0090
Verona, , Italy
Local Institution - 0222
Nagoya, Aichi-ken, Japan
Local Institution - 0217
Kashiwa, Chiba, Japan
Local Institution - 0219
Sapporo, Hokkaido, Japan
Local Institution - 0218
Yokohama, Kanagawa, Japan
Local Institution - 0216
Chuo-ku, Tokyo, Japan
Local Institution - 0220
Koto, Tokyo, Japan
Local Institution - 0221
Osaka, , Japan
Local Institution - 0258
Kuala Lumpur, Kuala Lumpur, Malaysia
Local Institution - 0256
Lembah Pantai, Kuala Lumpur, Malaysia
Local Institution - 0257
Kuching, Sarawak, Malaysia
Local Institution - 0364
Zapopan, Jalisco, Mexico
Local Institution - 0261
Cuauhtémoc, Ciudad de México, Mexico City, Mexico
Local Institution - 0260
Mexico City, Mexico City, Mexico
Local Institution - 0264
Monterrey, Nuevo León, Mexico
Local Institution - 0265
Oaxaca City, Oaxaca, Mexico
Local Institution - 0281
Querétaro City, Querétaro, Mexico
Local Institution - 0372
Mérida, Yucatán, Mexico
Local Institution - 0263
Mexico City, , Mexico
Local Institution - 0262
Puebla City, , Mexico
Local Institution - 0038
Maastricht, Limburg, Netherlands
Local Institution - 0039
Breda, North Brabant, Netherlands
Local Institution - 0277
Leiden, South Holland, Netherlands
Local Institution - 0037
Rotterdam, South Holland, Netherlands
Centrum Medyczne Pratia Poznań
Poznan, Greater Poland Voivodeship, Poland
Local Institution - 0280
Warsaw, Masovian Voivodeship, Poland
Local Institution - 0251
Gdask, Pomeranian Voivodeship, Poland
Local Institution - 0363
Gdansk, , Poland
Institutul Regional de Gastroenterologie și Hepatologie Prof. Dr. Octavian Fodor
Cluj-Napoca, Cluj, Romania
Local Institution - 0111
Florești, Cluj, Romania
Local Institution - 0110
Craiova, Dolj, Romania
Local Institution - 0114
Bucharest, , Romania
Local Institution - 0109
Bucharest, , Romania
Local Institution - 0113
Cluj-Napoca, , Romania
Local Institution - 0115
Cluj-Napoca, , Romania
Local Institution - 0107
Iași, , Romania
Local Institution - 0108
Ploieşti, , Romania
Local Institution - 0254
Singapore, Central Singapore, Singapore
Local Institution - 0255
Singapore, , Singapore
Local Institution - 0252
Singapore, , Singapore
Local Institution - 0253
Singapore, , Singapore
Local Institution - 0273
Košice, Košice Region, Slovakia
Local Institution - 0274
Trenčín, Trenčín Region, Slovakia
Local Institution - 0272
Banská Bystrica, , Slovakia
Local Institution - 0275
Bratislava, , Slovakia
Local Institution - 0246
Johannesburg, Gauteng, South Africa
Local Institution - 0241
Pretoria, Gauteng, South Africa
Local Institution - 0240
Soweto, Gauteng, South Africa
Local Institution - 0335
Cape Town, Western Cape, South Africa
Seoul National University Hospital
Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Asan Medical Center
Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Samsung Medical Center
Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Local Institution - 0003
Barcelona, Barcelona [Barcelona], Spain
Hospital Clínic de Barcelona
Barcelona, Catalunya [Cataluña], Spain
Local Institution - 0007
Madrid, Madrid, Comunidad de, Spain
Hospital Universitario 12 de Octubre
Madrid, Madrid, Comunidad de, Spain
Local Institution - 0002
Madrid, , Spain
Local Institution - 0006
Seville, , Spain
Hospital Universitario Miguel Servet
Zaragoza, , Spain
Local Institution - 0249
Lund, Skåne Län [se-12], Sweden
Karolinska Universitetssjukhuset Huddinge
Stockholm, Stockholms Län [se-01], Sweden
Akademiska sjukhuset
Uppsala, Uppsala Län [se-03], Sweden
Local Institution - 0118
Gothenburg, Västra Götalands Län [se-14], Sweden
Inselspital Bern
Bern, Canton of Bern, Switzerland
Cantonal Hospital St.Gallen
Sankt Gallen, Canton of St. Gallen, Switzerland
Ospedale Regionale Bellinzona e Valli
Bellinzona, Canton Ticino, Switzerland
Local Institution - 0234
Geneva, , Switzerland
China Medical University Hospital
Taichung, , Taiwan
National Taiwan University Hospital
Taipei, , Taiwan
Taipei Veterans General Hospital
Taipei, , Taiwan
Chang Gung Medical Foundation-Linkou Branch
Taoyuan District, , Taiwan
Local Institution - 0284
Stanbul, Istanbul, Turkey (Türkiye)
Local Institution - 0283
Adana, , Turkey (Türkiye)
Local Institution - 0286
Ankara, , Turkey (Türkiye)
Local Institution - 0287
Ankara, , Turkey (Türkiye)
Local Institution - 0285
Istanbul, , Turkey (Türkiye)
Local Institution - 0098
Birmingham, England, United Kingdom
Local Institution - 0014
London, England, United Kingdom
Royal Marsden Hospital (Chelsea)
London, Kensington and Chelsea, United Kingdom
Local Institution - 0248
London, London, City of, United Kingdom
Sarah Cannon Research Institute UK
London, London, City of, United Kingdom
Local Institution - 0235
Metropolitan Borough of Wirral, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
Role: CONTACT
First line of the email MUST contain the NCT# and Site #.
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Site 0142
Role: primary
Site 0365
Role: primary
J.Thaddeus Beck, Site 0306
Role: primary
Site 0373
Role: primary
Site 0157
Role: primary
Site 0139
Role: primary
Site 0367
Role: primary
Walid Shaib, Site 0193
Role: primary
Site 0126
Role: primary
Site 0168
Role: primary
Site 0125
Role: primary
Site 0370
Role: primary
Site 0371
Role: primary
Site 0145
Role: primary
Site 0245
Role: primary
Site 0120
Role: primary
Site 0191
Role: primary
Sreenivasa Chandana, Site 0192
Role: primary
Site 0182
Role: primary
Kelsey Klute, Site 0290
Role: primary
Site 0144
Role: primary
Site 0377
Role: primary
Site 0146
Role: primary
Site 0143
Role: primary
Site 0140
Role: primary
Site 0279
Role: primary
Site 0161
Role: primary
Site 0129
Role: primary
Site 0376
Role: primary
Sandeep Mashru, Site 0184
Role: primary
Site 0162
Role: primary
Yull Arriaga, Site 0250
Role: primary
Site 0301
Role: primary
Site 0158
Role: primary
Site 0368
Role: primary
Site 0289
Role: primary
Site 0167
Role: primary
Meredith Pelster, Site 0244
Role: primary
Andrew Paulson, Site 0196
Role: primary
Shubham Pant, Site 0164
Role: primary
Site 0170
Role: primary
Site 0344
Role: primary
Site 0159
Role: primary
Site 0348
Role: primary
Site 0169
Role: primary
Site 0337
Role: primary
Site 0195
Role: primary
Luciana Bella Quero, Site 0042
Role: primary
Juan Manuel O Connor, Site 0041
Role: primary
Site 0044
Role: primary
Ruben Segovia, Site 0069
Role: primary
Julieta Grasselli, Site 0040
Role: primary
Site 0045
Role: primary
Nick Pavlakis, Site 0227
Role: primary
Matthew Burge, Site 0228
Role: primary
Site 0226
Role: primary
Site 0229
Role: primary
Shehara Mendis, Site 0232
Role: primary
Site 0231
Role: primary
Kynan Feeney, Site 0230
Role: primary
Bernhard Doleschal, Site 0213
Role: primary
Lukas Weiss, Site 0223
Role: primary
Site 0211
Role: primary
Site 0031
Role: primary
Site 0035
Role: primary
Site 0065
Role: primary
Site 0063
Role: primary
Site 0033
Role: primary
Site 0032
Role: primary
Site 0034
Role: primary
Site 0102
Role: primary
Site 0291
Role: primary
Site 0101
Role: primary
Site 0074
Role: primary
Site 0104
Role: primary
Site 0071
Role: primary
Site 0100
Role: primary
Site 0075
Role: primary
Site 0332
Role: primary
Site 0199
Role: primary
Site 0200
Role: primary
Site 0202
Role: primary
Michael Raphael, Site 0201
Role: primary
Site 0203
Role: primary
Petr Kavan, Site 0215
Role: primary
Site 0048
Role: primary
Site 0046
Role: primary
Site 0047
Role: primary
Site 0312
Role: primary
Site 0331
Role: primary
Site 0346
Role: primary
Site 0310
Role: primary
Site 0307
Role: primary
Site 0297
Role: primary
Site 0352
Role: primary
Site 0313
Role: primary
Site 0302
Role: primary
Site 0295
Role: primary
Site 0353
Role: primary
Site 0357
Role: primary
Site 0293
Role: primary
Site 0354
Role: primary
Juan Du, Site 0303
Role: primary
Site 0311
Role: primary
Site 0304
Role: primary
Site 0345
Role: primary
Site 0299
Role: primary
Site 0334
Role: primary
Xianjun Yu, Site 0292
Role: primary
Site 0300
Role: primary
Site 0351
Role: primary
Xielin Feng, Site 0308
Role: primary
Site 0305
Role: primary
Chuntao Gao, Site 0314
Role: primary
Site 0356
Role: primary
Da Li, Site 0294
Role: primary
Site 0267
Role: primary
Site 0338
Role: primary
Site 0269
Role: primary
Site 0266
Role: primary
Site 0057
Role: primary
Site 0060
Role: primary
Site 0070
Role: primary
Site 0058
Role: primary
Site 0119
Role: primary
Site 0130
Role: primary
Site 0019
Role: primary
Site 0021
Role: primary
Site 0020
Role: primary
Lise Ventzel, Site 0018
Role: primary
Site 0067
Role: primary
Marine JARY, Site 0180
Role: primary
francois ghiringhelli, Site 0064
Role: primary
Site 0062
Role: primary
Rosine Guimbaud, Site 0026
Role: primary
Site 0068
Role: primary
Site 0029
Role: primary
Site 0025
Role: primary
Site 0238
Role: primary
Mathias Brugel, Site 0276
Role: primary
Antoine Hollebecque, Site 0030
Role: primary
Site 0066
Role: primary
Site 0028
Role: primary
Site 0309
Role: primary
Site 0242
Role: primary
Site 0209
Role: primary
Alexander Koenig, Site 0204
Role: primary
Site 0205
Role: primary
Jack Chater Cure, Site 0243
Role: primary
Site 0224
Role: primary
Rene Pschowski, Site 0236
Role: primary
Site 0206
Role: primary
Alexander Stein, Site 0207
Role: primary
Site 0208
Role: primary
Site 0085
Role: primary
Site 0086
Role: primary
Site 0084
Role: primary
Site 0259
Role: primary
Site 0091
Role: primary
Site 0082
Role: primary
Site 0083
Role: primary
Site 0271
Role: primary
Site 0270
Role: primary
Site 0188
Role: primary
Site 0152
Role: primary
Site 0179
Role: primary
Site 0190
Role: primary
Site 0147
Role: primary
Site 0154
Role: primary
Site 0153
Role: primary
Site 0225
Role: primary
Site 0078
Role: primary
Site 0080
Role: primary
Site 0097
Role: primary
Site 0077
Role: primary
Site 0076
Role: primary
Site 0081
Role: primary
Ilario Rapposelli, Site 0095
Role: primary
Site 0092
Role: primary
Filippo Pietrantonio, Site 0089
Role: primary
Lorenza Rimassa, Site 0088
Role: primary
Site 0096
Role: primary
Site 0093
Role: primary
Site 0247
Role: primary
Roberto Bianco, Site 0094
Role: primary
Site 0090
Role: primary
Site 0222
Role: primary
Site 0217
Role: primary
Site 0219
Role: primary
Site 0218
Role: primary
Site 0216
Role: primary
Site 0220
Role: primary
Site 0221
Role: primary
Site 0258
Role: primary
Site 0256
Role: primary
Site 0257
Role: primary
Site 0364
Role: primary
Site 0261
Role: primary
Site 0260
Role: primary
Site 0264
Role: primary
Site 0265
Role: primary
Site 0281
Role: primary
Site 0372
Role: primary
Site 0262
Role: primary
Site 0038
Role: primary
Site 0039
Role: primary
Site 0277
Role: primary
Site 0037
Role: primary
Marek Kotlarski, Site 0278
Role: primary
Site 0280
Role: primary
Site 0251
Role: primary
Site 0363
Role: primary
Adrian Radu Vidra, Site 0112
Role: primary
Site 0111
Role: primary
Site 0110
Role: primary
Site 0114
Role: primary
Site 0109
Role: primary
Site 0113
Role: primary
Site 0115
Role: primary
Site 0107
Role: primary
Site 0108
Role: primary
Site 0254
Role: primary
Site 0255
Role: primary
Site 0252
Role: primary
Site 0253
Role: primary
Site 0273
Role: primary
Site 0274
Role: primary
Site 0272
Role: primary
Site 0275
Role: primary
Site 0246
Role: primary
Site 0241
Role: primary
Site 0240
Role: primary
Site 0335
Role: primary
Do-Youn Oh, Site 0049
Role: primary
Changhoon Yoo, Site 0051
Role: primary
Joon Oh Park, Site 0050
Role: primary
Site 0003
Role: primary
Ismael Macias Declara, Site 0005
Role: primary
Site 0007
Role: primary
Rocio Garcia Carbonero, Site 0004
Role: primary
Site 0002
Role: primary
Site 0006
Role: primary
Roberto Pazo Cid, Site 0001
Role: primary
Site 0249
Role: primary
Marco Gerling, Site 0023
Role: primary
Henning Karlsson, Site 0022
Role: primary
Site 0118
Role: primary
Martin Berger, Site 0212
Role: primary
Markus Joerger, Site 0214
Role: primary
Sara De Dosso, Site 0210
Role: primary
Site 0234
Role: primary
Li-Yuan Bai, Site 0052
Role: primary
Chih-Hung Hsu, Site 0056
Role: primary
Nai-Jung Chiang, Site 0053
Role: primary
Wen-Chi Chou, Site 0054
Role: primary
Site 0284
Role: primary
Site 0283
Role: primary
Site 0286
Role: primary
Site 0287
Role: primary
Site 0285
Role: primary
Site 0098
Role: primary
Site 0014
Role: primary
Justin Mencel, Site 0017
Role: primary
Site 0248
Role: primary
Elisa Fontana, Site 0013
Role: primary
Site 0235
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
BMS Clinical Trial Information
BMS Clinical Trial Patient Recruiting
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-522598-12
Identifier Type: OTHER
Identifier Source: secondary_id
U1111-1320-4708
Identifier Type: OTHER
Identifier Source: secondary_id
CA2400030
Identifier Type: OTHER
Identifier Source: secondary_id
CA240-0030
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.